Teva Pharmaceuticals USA, Inc
36 FDA enforcement actions
36 Total Recalls
2 Class I
22 Class II
12 Class III
Firm Details
- Product Types
- drug
- States
- NJ
All Recalls
- Class III: Low Risk 11/07/2025 drug
- Class II: Risk 10/13/2025 drug
- Class II: Risk 10/07/2025 drug
- Class II: Risk 10/07/2025 drug
- Class II: Risk 10/07/2025 drug
- Class II: Risk 05/23/2025 drug
- Class II: Risk 01/10/2025 drug
- Class II: Risk 08/08/2024 drug
- Class II: Risk 06/28/2024 drug
- Class II: Risk 06/04/2024 drug
- Class II: Risk 03/28/2024 drug
- Class II: Risk 03/07/2024 drug
- Class III: Low Risk 01/25/2024 drug
- Class III: Low Risk 01/25/2024 drug
- Class II: Risk 01/08/2024 drug
- Class III: Low Risk 11/10/2023 drug
- Class II: Risk 07/05/2023 drug
- Class III: Low Risk 04/27/2023 drug
- Class III: Low Risk 04/27/2023 drug
- Class III: Low Risk 04/27/2023 drug
- Class III: Low Risk 04/27/2023 drug
- Class III: Low Risk 04/27/2023 drug
- Class III: Low Risk 03/27/2023 drug
- Class II: Risk 02/23/2023 drug
- Class II: Risk 02/22/2023 drug
- Class II: Risk 08/29/2022 drug
- Class II: Risk 08/23/2022 drug
- Class III: Low Risk 07/22/2022 drug
- Class II: Risk 07/21/2022 drug
- Class II: Risk 07/21/2022 drug
- Class II: Risk 06/29/2022 drug
- Class II: Risk 06/14/2022 drug
- Class III: Low Risk 05/18/2022 drug
- Class I: Dangerous 05/11/2022 drug
- Class II: Risk 04/15/2022 drug
- Class I: Dangerous 03/29/2022 drug
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.